Non- albicans Candida Species: Immune Response, Evasion Mechanisms, and New Plant-Derived Alternative Therapies.
Manuela Gómez-GaviriaUriel Ramírez-SoteloHéctor Manuel Mora-MontesPublished in: Journal of fungi (Basel, Switzerland) (2022)
Fungal infections caused by Candida species have become a constant threat to public health, especially for immunocompromised patients, who are considered susceptible to this type of opportunistic infections. Candida albicans is known as the most common etiological agent of candidiasis; however, other species, such as Candida tropicalis , Candida parapsilosis , Nakaseomyces glabrata (previously known as Candida glabrata ), Candida auris , Candida guilliermondii , and Pichia kudriavzevii (previously named as Candida krusei ), have also gained great importance in recent years. The increasing frequency of the isolation of this non- albicans Candida species is associated with different factors, such as constant exposure to antifungal drugs, the use of catheters in hospitalized patients, cancer, age, and geographic distribution. The main concerns for the control of these pathogens include their ability to evade the mechanisms of action of different drugs, thus developing resistance to antifungal drugs, and it has also been shown that some of these species also manage to evade the host's immunity. These biological traits make candidiasis treatment a challenging task. In this review manuscript, a detailed update of the recent literature on the six most relevant non- albicans Candida species is provided, focusing on the immune response, evasion mechanisms, and new plant-derived compounds with antifungal properties.
Keyphrases
- candida albicans
- biofilm formation
- immune response
- public health
- end stage renal disease
- systematic review
- escherichia coli
- chronic kidney disease
- intensive care unit
- dna methylation
- gene expression
- genetic diversity
- dendritic cells
- multidrug resistant
- patient reported outcomes
- genome wide
- staphylococcus aureus
- acute respiratory distress syndrome
- inflammatory response
- lymph node metastasis